Difference Between FDA 21 CFR Part 820 and ISO 13485
Overview: Difference Between FDA 21 CFR Part 820 and ISO 13485
The core difference between FDA 21 CFR Part 820 and ISO 13485 lies in their scope, regulatory authority, and legal enforceability. FDA 21 CFR Part 820 (historically known as the Quality System Regulation or QSR, now updated under the Quality Management System Regulation or QMSR) is a mandatory U.S. federal law enforced by the Food and Drug Administration for finished devices sold in the United States. ISO 13485 is an internationally recognized voluntary standard that outlines quality management requirements globally. While the FDA harmonized Part 820 by incorporating ISO 13485:2016 by reference under the QMSR final rule, the FDA maintains specific U.S. regulatory bridge requirements, including stringent labeling controls (§ 820.45), complaint tracking, and adverse event reporting.
Contact Us
Navigating FDA 21 CFR 820 and ISO 13485 Compliance
Over more than 20 years in regulatory affairs and quality management, implementing a quality framework that enables effective product development while adhering to both domestic and international requirements has proven to be a complex task. Medical device organizations must maintain rigorous gmp compliance and establish an audit-ready framework that satisfies both domestic and global health authorities.
Understanding the operational variations and legal consequences of these frameworks is essential for quality managers and medical device executives. To evaluate your organization’s compliance architecture, manufacturers often analyze the foundational importance of FDA 21 CFR Part 820 and ISO 13485 by their differences.
What is 21 CFR Part 820?
When understanding what is the 21 cfr, title 21 of the Code of Federal Regulations contains the federal mandates governing food, drugs, and medical products in the United States. Specifically, FDA 21 CFR Part 820—traditionally known as the Quality System Regulation (QSR)—focuses on Current Good Manufacturing Practices (CGMP guidelines).
This regulation governs the methods, facilities, and controls used for the design, manufacturing, packaging, labeling, storage, installation, and servicing of all finished medical devices produced for human use. These requirements ensure finished medical products remain safe, reliable, and effective. Device manufacturers marketing products in the U.S. must undergo routine FDA facility inspections to verify full FDA 21 CFR 820 compliance.
What is ISO 13485?
When defining what is ISO 13485, it is an internationally agreed-upon gmp standard for medical device quality management systems. ISO 13485 specifies criteria for a quality framework where an organization must demonstrate its technical capability to supply medical devices and related services that consistently meet customer expectations and international regulatory mandates.
Organizations can utilize ISO 13485 across any stage of the product lifecycle, including:
Design and development
gmp manufacturing and quality engineering
Storage, logistics, and distribution
Servicing, installation, and technical support
Provision of raw materials, software components, or calibration services
Unlike static regulations, ISO 13485 serves as a universal baseline used by notified bodies and global regulatory authorities across Europe, Canada, Japan, Australia, and beyond.
The Core Relationship Between ISO 13485 and 21 CFR Part 820
Historically, structural differences kept ISO 13485 and 21 CFR 820 operating as parallel frameworks. Early iterations of ISO 13485 were modeled after general ISO 9001 standards. Although the FDA actively participated in developing ISO 13485 to align international expectations, the agency maintained stricter U.S. rules regarding complaint handling, Medical Device Reporting (MDR), and Device History Records (DHR).
The FDA QMSR Harmonization Epoch
Under the FDA’s Quality Management System Regulation (QMSR) final rule, the FDA officially updated FDA 21 CFR Part 820 by incorporating ISO 13485:2016 by reference. This harmonization stream aligns core quality system requirements globally while reducing duplicate documentation burdens for international device manufacturers.
However, holding an ISO 13485 certificate alone does not grant automatic compliance with FDA rules. The FDA retains specific country-tailored rules, including:
Device Labeling and Packaging Controls (§ 820.45): Specific mandatory checks before label release.
Control of Records (§ 820.35): Inspection access to management reviews and internal audit reports.
Medical Device Reporting (21 CFR Part 803) & UDI (21 CFR Part 830): U.S. adverse event and unique device tracking laws.
Schedule a Compliance Consultation
Accelerate Market Access with End-to-End Regulatory Guidance
Key Differences: FDA 21 CFR Part 820 vs. ISO 13485
While harmonization bridges most process requirements, key functional differences remain:
Record Terminology & Structure: ISO 13485 uses the term Medical Device File (MDF), whereas legacy 21 CFR 820 referenced Device Master Records (DMR) and Design History Files (DHF). Modern systems integrate both under unified data architectures.
Inspection Scope: FDA investigators operate under legal authority to inspect manufacturing facilities for CGMP compliance, while ISO 13485 registrars conduct scheduled audits for certificate maintenance.
Management Representation: ISO 13485 emphasizes executive leadership responsibility (“Top Management”), whereas traditional QSR relied heavily on designated management representatives.
Risk Management Integration: ISO 13485 embeds risk-based decision-making throughout all QMS processes (referencing ISO 14971), which FDA QMSR now explicitly mandates across design, supply chain, and production activities.
A comprehensive gap analysis performed by specialized consultants ensures that an existing ISO 13485 framework incorporates the precise supplementary controls required under 21 CFR Part 820.
FDA 21 CFR Part 820 FAQs: Understand U.S. quality system requirements, ISO 13485 alignment, and QMSR compliance rules in our complete guide to 21 CFR Part 820 FAQs for medical devices.
Accelerating FDA 21 CFR 820 & ISO 13485 Compliance with Operon Strategist
Operon Strategist provides specialized regulatory and quality engineering support to help medical device companies build, harmonize, and maintain audit-ready quality management systems:
Dual QMS Architecture & Gap Analysis: Evaluating existing quality systems against both ISO 13485:2016 and FDA 21 CFR Part 820 (QMSR) requirements to eliminate redundant procedures.
Technical File & Medical Device File (MDF) Compilation: Structuring compliant design controls, risk management files (ISO 14971), and manufacturing validation records.
FDA Inspection & Audit Preparedness: Mock FDA audits, inspection front-room/back-room playbook training, and response management for FDA Form 483 observations.
CGMP & Labeling Controls Implementation: Aligning facility layouts, sanitation, packaging operations, and unique device identification (UDI) with FDA § 820.45 rules.
Ongoing Post-Market Compliance Support: Managing CAPA systems, complaint handling workflows, Medical Device Reporting (MDR), and internal quality audits.
Ensure Seamless Regulatory Compliance for Your Device
Get Your Medical Device Market-Ready with Expert Regulatory Support
FAQ's
What is the main difference between FDA 21 CFR Part 820 and ISO 13485?
21 CFR Part 820 is a mandatory U.S. federal regulation enforced by the FDA, whereas ISO 13485 is a voluntary international QMS standard
Does ISO 13485 certification grant automatic FDA compliance?
No, ISO 13485 certification does not grant immunity from FDA inspections or guarantee full compliance with U.S.-specific FDA rules.
What is FDA QMSR harmonization?
FDA QMSR (Quality Management System Regulation) updated 21 CFR Part 820 by incorporating ISO 13485:2016 by reference while retaining specific U.S. regulatory controls.
What is a Medical Device File (MDF)?
A Medical Device File (MDF) is an ISO 13485 record compilation containing specifications, manufacturing protocols, and quality procedures for a specific device type.
Are internal audit records inspectable during an FDA inspection under QMSR?
Yes, under updated QMSR rules, internal audits, management reviews, and supplier audits are subject to FDA inspection review.